Search / Trial NCT06228170

Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients

Launched by ZENG CHANGHAO · Jan 19, 2024

Trial Information

Current as of December 30, 2024

Withdrawn

Keywords

ClinConnect Summary

Dysphagia, or swallowing difficulty, is a common symptom in Traumatic Brain Injury Patients. The goal of this or clinical trial is to explore efficacy of stellate ganglion block on dysphagia and activities of daily living in Traumatic Brain Injury Patients. The main question it aims to answer are:

Can stellate ganglion block improve the dysphagia and activities of daily living in Traumatic Brain Injury Patients.

Traumatic Brain Injury Patients will be divided into the the control group and observation group evenly. All the patients were provided with routine therapy, while the patients in...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age ≥ 18 years, meeting the diagnosis of Traumatic Brain Injury;
  • presence of no contraindication for Stellate Ganglion Block;
  • with stable vital signs and no severe liver or kidney dysfunction, metabolic disorders, cardiovascular diseases, or multiple complications;
  • informed consent form was obtained from the patient\'s family members, indicating their full understanding of the study and agreement to participate.
  • Exclusion Criteria:
  • unable to cooperate in completing treatment and assessment due to personal reasons or other disorders;
  • complicated with other intracranial lesions, such as stroke;
  • with severe consciousness disorders caused by other diseases.

Trial Officials

Nieto Luis, Master

Study Director

Site Coordinator of United Medical Group located in Miami

About Zeng Changhao

Zeng Changhao is a dedicated clinical trial sponsor focused on advancing medical research and innovation through rigorous and ethically conducted clinical studies. With a commitment to improving patient outcomes, Zeng Changhao collaborates with leading healthcare professionals and research institutions to explore novel therapies and treatment modalities. The organization emphasizes transparency, compliance, and patient safety, ensuring that all trials adhere to the highest regulatory standards. Through its strategic partnerships and a patient-centric approach, Zeng Changhao aims to contribute significantly to the development of effective and safe healthcare solutions.

Locations

Zhengzhou, Henan, China

Mianyang, Sichuan, China

Zhengzhou, Henan, China

Zhengzhou, Henan, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0